Sound View Wealth Advisors Group LLC Sells 86 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Share on StockTwits

Sound View Wealth Advisors Group LLC cut its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 3.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,229 shares of the financial services provider’s stock after selling 86 shares during the period. Sound View Wealth Advisors Group LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $305,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Triangle Securities Wealth Management increased its position in iShares Nasdaq Biotechnology ETF by 3.8% during the second quarter. Triangle Securities Wealth Management now owns 2,067 shares of the financial services provider’s stock worth $283,000 after acquiring an additional 75 shares during the period. AFT Forsyth AND Company Inc. grew its stake in iShares Nasdaq Biotechnology ETF by 1.8% during the second quarter. AFT Forsyth AND Company Inc. now owns 4,176 shares of the financial services provider’s stock worth $571,000 after buying an additional 75 shares in the last quarter. Danda Trouve Investment Management Inc. increased its holdings in iShares Nasdaq Biotechnology ETF by 1.0% in the 2nd quarter. Danda Trouve Investment Management Inc. now owns 8,085 shares of the financial services provider’s stock valued at $1,105,000 after buying an additional 82 shares during the period. Evanson Asset Management LLC increased its holdings in iShares Nasdaq Biotechnology ETF by 2.8% in the 1st quarter. Evanson Asset Management LLC now owns 3,727 shares of the financial services provider’s stock valued at $402,000 after buying an additional 100 shares during the period. Finally, Patriot Financial Group Insurance Agency LLC raised its position in shares of iShares Nasdaq Biotechnology ETF by 13.2% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 856 shares of the financial services provider’s stock valued at $117,000 after buying an additional 100 shares in the last quarter. 71.40% of the stock is currently owned by hedge funds and other institutional investors.

Separately, ValuEngine cut shares of iShares Nasdaq Biotechnology ETF from a “hold” rating to a “sell” rating in a research note on Thursday, July 2nd.

Shares of IBB traded down $0.75 during midday trading on Thursday, hitting $133.03. The company’s stock had a trading volume of 57,898 shares, compared to its average volume of 2,763,688. The company’s fifty day simple moving average is $137.89 and its two-hundred day simple moving average is $125.67. iShares Nasdaq Biotechnology ETF has a one year low of $92.15 and a one year high of $146.53.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: Fundamental Analysis and Individual Investors

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply